{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T09:43:03Z","timestamp":1791020583209,"version":"4.1.0"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2008,1,1]],"date-time":"2008-01-01T00:00:00Z","timestamp":1199145600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Treat Options Neurol"],"published-print":{"date-parts":[[2008,1]]},"DOI":"10.1007\/s11940-008-0003-3","type":"journal-article","created":{"date-parts":[[2008,2,6]],"date-time":"2008-02-06T16:12:44Z","timestamp":1202314364000},"page":"20-29","source":"Crossref","is-referenced-by-count":59,"title":["Update on the prophylaxis of migraine"],"prefix":"10.1007","volume":"10","author":[{"given":"Markus","family":"Sch\u00fcrks","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans-Christoph","family":"Diener","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Goadsby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2008,2,7]]},"reference":[{"key":"3_CR1","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1212\/01.wnl.0000252808.97649.21","volume":"68","author":"R.B. Lipton","year":"2007","unstructured":"Lipton RB, Bigal ME, Diamond M, et al.: Migraine prevalence, disease burden, and the need for preventive therapy. Neurology 2007, 68:343\u2013349.","journal-title":"Neurology"},{"key":"3_CR2","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1046\/j.0306-5251.2001.01459.x","volume":"52","author":"V. Limmroth","year":"2001","unstructured":"Limmroth V, Michel MC: The prevention of migraine: a critical review with special emphasis on beta-adrenoceptor blockers. Br J Clin Pharmacol 2001, 52:237\u2013243.","journal-title":"Br J Clin Pharmacol"},{"key":"3_CR3","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1111\/j.1526-4610.1991.hed3105333.x","volume":"31","author":"K.A. Holroyd","year":"1991","unstructured":"Holroyd KA, Penzien DB, Cordingley GE: Propranolol in the management of recurrent migraine: a meta-analytic review. Headache 1991, 31:333\u2013340.","journal-title":"Headache"},{"key":"3_CR4","doi-asserted-by":"crossref","first-page":"2500","DOI":"10.1001\/jama.1983.03340180054025","volume":"250","author":"G.D. Solomon","year":"1983","unstructured":"Solomon GD, Steel JG, Spaccavento LJ: Verapamil prophylaxis of migraine: a double-blind, placebo-controlled study. JAMA 1983, 250:2500\u20132502.","journal-title":"JAMA"},{"key":"3_CR5","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1001\/jama.291.8.965","volume":"291","author":"J. Brandes","year":"2004","unstructured":"Brandes J, Saper J, Diamond M, et al.: Topiramate for migraine prevention: a randomized controlled trial. JAMA 2004, 291:965\u2013973.","journal-title":"JAMA"},{"key":"3_CR6","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1007\/s00415-004-0464-6","volume":"251","author":"H.C. Diener","year":"2004","unstructured":"Diener HC, Tfelt-Hansen P, Dahl\u00f6f C, et al.: Topiramate in migraine prophylaxis: results from a placebo-controlled trial with propranolol as an active control. J Neurol 2004, 251:943\u2013950.","journal-title":"J Neurol"},{"key":"3_CR7","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1001\/archneur.61.4.490","volume":"61","author":"S.D. Silberstein","year":"2004","unstructured":"Silberstein SD, Neto W, Schmitt J, et al.: Topiramate in migraine prevention: results of a large controlled trial. Arch Neurol 2004, 61:490\u2013495.","journal-title":"Arch Neurol"},{"key":"3_CR8","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1111\/j.1526-4610.2007.00648.x","volume":"47","author":"V. Limmroth","year":"2007","unstructured":"Limmroth V, Biondi D, Pfeil J, Schwalen S: Topiramate in patients with episodic migraine: reducing the risk for chronic forms of headache. Headache 2007, 47:13\u201321.","journal-title":"Headache"},{"key":"3_CR9","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1111\/j.1468-2982.2007.01326.x","volume":"27","author":"H.C. Diener","year":"2007","unstructured":"Diener HC, Bussone G, Van Oene J, et al.: Topiramate reduces headache days in chronic migraine: a randomized, double-blind, placebo-controlled study. Cephalalgia 2007, 27:814\u2013823.","journal-title":"Cephalalgia"},{"key":"3_CR10","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1111\/j.1526-4610.2006.00684.x","volume":"47","author":"S.D. Silberstein","year":"2007","unstructured":"Silberstein SD, Lipton RB, Dodick DW, et al.: Efficacy and safety of topiramate for the treatment of chronic migraine: a randomized, double-blind, placebo-controlled trial. Headache 2007, 47:170\u2013180.","journal-title":"Headache"},{"key":"3_CR11","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1111\/j.1526-4610.2007.00754.x","volume":"47","author":"S.D. Silberstein","year":"2007","unstructured":"Silberstein SD, Feliu AL, Rupnow MF, et al.: Topiramate in migraine prophylaxis: long-term impact on resource utilization and cost. Headache 2007, 47:500\u2013510.","journal-title":"Headache"},{"key":"3_CR12","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1046\/j.1468-2982.1997.1702109.x","volume":"17","author":"T.J. Steiner","year":"1997","unstructured":"Steiner TJ, Findley LJ, Yuen AWC: Lamotrigine versus placebo in the prophylaxis of migraine with and without aura. Cephalalgia 1997, 17:109\u2013112.","journal-title":"Cephalalgia"},{"key":"3_CR13","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1136\/jnnp.2005.063750","volume":"76","author":"C. Lampl","year":"2005","unstructured":"Lampl C, Katsarava Z, Diener HC, Limmroth V: Lamotrigine reduces migraine aura and migraine attacks in patients with migraine with aura. J Neurol Neurosurg Psychiatry 2005, 76:1730\u20131732.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"3_CR14","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1046\/j.1526-4610.2001.111006119.x","volume":"41","author":"N.T. Mathew","year":"2001","unstructured":"Mathew NT, Rapoport A, Saper J, et al.: Efficacy of gabapentin in migraine prophylaxis. Headache 2001, 41:119\u2013128.","journal-title":"Headache"},{"key":"3_CR15","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1097\/01.wnf.0000150866.98887.77","volume":"27","author":"M.E. Drake Jr","year":"2004","unstructured":"Drake ME Jr, Greathouse NI, Renner JB, Armentbright AD: Open-label zonisamide for refractory migraine. Clin Neuropharmacol 2004, 27:278\u2013280.","journal-title":"Clin Neuropharmacol"},{"key":"3_CR16","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1111\/j.1526-4610.2006.00455.x","volume":"46","author":"A. Pakalnis","year":"2006","unstructured":"Pakalnis A, Kring D: Zonisamide prophylaxis in refractory pediatric headache. Headache 2006, 46:804\u2013807.","journal-title":"Headache"},{"key":"3_CR17","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1111\/j.1468-2982.2006.01191.x","volume":"26","author":"A. Ashkenazi","year":"2006","unstructured":"Ashkenazi A, Benlifer A, Korenblit J, Silberstein SD: Zonisamide for migraine prophylaxis in refractory patients. Cephalalgia 2006, 26:1199\u20131202.","journal-title":"Cephalalgia"},{"key":"3_CR18","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1046\/j.1468-2982.1998.1807421.x","volume":"18","author":"S.D. Silberstein","year":"1998","unstructured":"Silberstein SD: Methysergide. Cephalalgia 1998, 18:421\u2013435.","journal-title":"Cephalalgia"},{"key":"3_CR19","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1046\/j.1468-2982.1986.0601015.x","volume":"6","author":"R. Cerbo","year":"1986","unstructured":"Cerbo R, Casacchia M, Formisano R, et al.: Flunarizinepizotifen single-dose double-blind cross-over trial in migraine prophylaxis. Cephalalgia 1986, 6:15\u201318.","journal-title":"Cephalalgia"},{"key":"3_CR20","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1046\/j.1468-2982.2001.00182.x","volume":"21","author":"H.C. Diener","year":"2001","unstructured":"Diener HC, Hartung E, Chrubasik J, et al.: A comparative study of acetylsalicyclic acid and metoprolol for the prophylactic treatment of migraine. A randomised, controlled, double-blind, parallel group phase III study. Cephalalgia 2001, 21:140\u2013144.","journal-title":"Cephalalgia"},{"key":"3_CR21","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1177\/03331024860060S411","volume":"6","author":"K.M.A. Welch","year":"1986","unstructured":"Welch KMA: Naproxen sodium in the treatment of migraine. Cephalalgia 1986, 6:85\u201392.","journal-title":"Cephalalgia"},{"key":"3_CR22","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1001\/archneur.1979.00500470065013","volume":"36","author":"J.R. Couch","year":"1979","unstructured":"Couch JR, Hassanein RS: Amitriptyline in migraine prophylaxis. Arch Neurol 1979, 36:695\u2013699.","journal-title":"Arch Neurol"},{"key":"3_CR23","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1001\/archneur.1987.00520170016015","volume":"44","author":"D.K. Ziegler","year":"1987","unstructured":"Ziegler DK, Hurwitz A, Hassanein RS, et al.: Migraine prophylaxis. A comparison of propranolol and amitriptyline. Arch Neurol 1987, 44:486\u2013489.","journal-title":"Arch Neurol"},{"key":"3_CR24","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1111\/j.1526-4610.2005.05029.x","volume":"45","author":"S.N. Ozyalcin","year":"2005","unstructured":"Ozyalcin SN, Talu GK, Kiziltan E, et al.: The efficacy and safety of venlafaxine in the prophylaxis of migraine. Headache 2005, 45:144\u2013152.","journal-title":"Headache"},{"key":"3_CR25","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1111\/j.1526-4610.1992.hed3208416.x","volume":"32","author":"A. Kuritzky","year":"1992","unstructured":"Kuritzky A, Zoldan Y, Melamed E: Selegeline, a MAO B inhibitor, is not effective in the prophylaxis of migraine without aura\u2014an open study. Headache 1992, 32:416.","journal-title":"Headache"},{"key":"3_CR26","doi-asserted-by":"crossref","unstructured":"Moja PL, Cusi C, Sterzi RR, Canepari C: Selective serotonin re-uptake inhibitors (SSRIs) for preventing migraine and tension-type headaches. Cochrane Database Syst Rev 2005:CD002919.","DOI":"10.1002\/14651858.CD002919.pub2"},{"key":"3_CR27","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1136\/bmj.322.7277.19","volume":"322","author":"H. Schrader","year":"2001","unstructured":"Schrader H, Stovner LJ, Helde G, et al.: Prophylactic treatment of migraine with angiotensin converting enzyme inhibitor (lisinopril): randomised, placebo controlled, crossover study. BMJ 2001, 322:19\u201322.","journal-title":"BMJ"},{"key":"3_CR28","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1001\/jama.289.1.65","volume":"289","author":"E. Tronvik","year":"2003","unstructured":"Tronvik E, Stovner L, Helde G, et al.: Prophylactic treatment of migraine with an angiotensin II receptor blocker: a randomized controlled trial. JAMA 2003, 289:65\u201369.","journal-title":"JAMA"},{"key":"3_CR29","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1111\/j.1526-4610.2006.00382.x","volume":"46","author":"J.A. Charles","year":"2006","unstructured":"Charles JA, Jotkowitz S, Byrd LH: Prevention of migraine with olmesartan in patients with hypertension\/prehypertension. Headache 2006, 46:503\u2013507.","journal-title":"Headache"},{"key":"3_CR30","doi-asserted-by":"crossref","first-page":"430","DOI":"10.5414\/CPP38430","volume":"38","author":"M. Grossmann","year":"2000","unstructured":"Grossmann M, Schmidramsl H: An extract of Petasites hybridus is effective in the prophylaxis of migraine. Inter J Clin Pharmacol Therapeutics 2000, 38:430\u2013435.","journal-title":"Inter J Clin Pharmacol Therapeutics"},{"key":"3_CR31","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1159\/000076535","volume":"51","author":"H.C. Diener","year":"2004","unstructured":"Diener HC, Rahlfs VW, Danesch U: The first placebo-controlled trial of a special butterbur root extract for the prevention of migraine: reanalysis of efficacy criteria. Eur Neurol 2004, 51:89\u201397.","journal-title":"Eur Neurol"},{"key":"3_CR32","doi-asserted-by":"crossref","first-page":"2240","DOI":"10.1212\/01.WNL.0000147290.68260.11","volume":"63","author":"R.B. Lipton","year":"2004","unstructured":"Lipton RB, Gobel H, Einhaupl KM, et al.: Petasites hybridus root (butterbur) is an effective preventive treatment for migraine. Neurology 2004, 63:2240\u20132244.","journal-title":"Neurology"},{"key":"3_CR33","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1111\/j.1468-2982.2005.00950.x","volume":"25","author":"H.C. Diener","year":"2005","unstructured":"Diener HC, Pfaffenrath V, Schnitker J, et al.: Efficacy and safety of 6.25 mg t.i.d. feverfew CO2-extract (MIG-99) in migraine prevention\u2014a randomized, double-blind, multicentre, placebo-controlled study. Cephalalgia 2005, 25:1031\u20131041.","journal-title":"Cephalalgia"},{"key":"3_CR34","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1046\/j.1468-2982.2002.00396.x","volume":"22","author":"V. Pfaffenrath","year":"2002","unstructured":"Pfaffenrath V, Diener HC, Fischer M, et al.: on behalf of the Investigators. The efficacy and safety of Tanacetum parthenium (feverfew) in migraine prophylaxis\u2014a double-blind, multicentre, randomized placebo-controlled dose-response study. Cephalalgia 2002, 22:523\u2013532.","journal-title":"Cephalalgia"},{"key":"3_CR35","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1002\/(SICI)1099-1573(199711)11:7<508::AID-PTR153>3.0.CO;2-H","volume":"11","author":"D. Palevitch","year":"1997","unstructured":"Palevitch D, Earon G, Carasso R. Feverfew (Tanacetum parthenium) as a prophylactic treatment for migraine\u2014a double-blind placebo-controlled study. Phytother Res 1997, 11:508\u2013511.","journal-title":"Phytother Res"},{"key":"3_CR36","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S0140-6736(88)92289-1","volume":"2","author":"J.J. Murphy","year":"1988","unstructured":"Murphy JJ, Heptinstall S, Mitchell JRA: Randomized double-blind placebo-controlled trial of feverfew in migraine prevention. Lancet 1988, 2:189\u2013192.","journal-title":"Lancet"},{"key":"3_CR37","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1136\/bmj.291.6495.569","volume":"291","author":"E.S. Johnson","year":"1985","unstructured":"Johnson ES, Kadam NP, Hylands DM, Hylands PJ: Efficacy of feverfew as a prophylactic treatment of migraine. BMJ 1985, 291:569\u2013573.","journal-title":"BMJ"},{"key":"3_CR38","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1046\/j.1468-2982.1996.1604257.x","volume":"16","author":"A. Peikert","year":"1996","unstructured":"Peikert A, Wilimzig C, K\u00f6hne-Volland R: Prophylaxis of migraine with oral magnesium: results from a prospective, multi-center, placebo-controlled and double-blind randomized study. Cephalalgia 1996, 16:257\u2013263.","journal-title":"Cephalalgia"},{"key":"3_CR39","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1046\/j.1468-2982.1996.1606436.x","volume":"16","author":"V. Pfaffenrath","year":"1996","unstructured":"Pfaffenrath V, Wessely P, Mener C, et al.: Magnesium in the prophylaxis of migraine\u2014a double-blind placebo-controlled study. Cephalalgia 1996, 16:436\u2013440.","journal-title":"Cephalalgia"},{"key":"3_CR40","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1212\/WNL.50.2.466","volume":"50","author":"J. Schoenen","year":"1998","unstructured":"Schoenen J, Jacquy J, Lenaerts M: Effectiveness of high-dose riboflavin in migraine prophylaxis-a randomized controlled trial. Neurology 1998, 50:466\u2013470.","journal-title":"Neurology"},{"key":"3_CR41","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1212\/01.WNL.0000151975.03598.ED","volume":"64","author":"P.S. Sandor","year":"2005","unstructured":"Sandor PS, Di Clemente L, Coppola G, et al.: Efficacy of coenzyme Q10 in migraine prophylaxis: a randomized controlled trial. Neurology 2005, 64:713\u2013715.","journal-title":"Neurology"},{"key":"3_CR42","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1111\/j.1526-4610.2006.00626.x","volume":"47","author":"D. Magis","year":"2007","unstructured":"Magis D, Ambrosini A, Sandor P, et al.: A randomized double-blind placebo-controlled trial of thioctic acid in migraine prophylaxis. Headache 2007, 47:52\u201357.","journal-title":"Headache"},{"key":"3_CR43","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1111\/j.1526-4610.2007.00853.x","volume":"47","author":"S.K. Aurora","year":"2007","unstructured":"Aurora SK, Gawel M, Brandes JL, et al.: Botulinum toxin type A prophylactic treatment of episodic migraine: a randomized, double-blind, placebo-controlled exploratory study. Headache 2007, 47:486\u2013499.","journal-title":"Headache"},{"key":"3_CR44","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1016\/j.jpain.2006.03.002","volume":"7","author":"A.H. Elkind","year":"2006","unstructured":"Elkind AH, O\u2019Carroll P, Blumenfeld A, et al.: A series of three sequential, randomized, controlled studies of repeated treatments with botulinum toxin type A for migraine prophylaxis. J Pain 2006, 7:688\u2013696.","journal-title":"J Pain"},{"key":"3_CR45","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1111\/j.1468-2982.2004.00754.x","volume":"24","author":"S. Evers","year":"2004","unstructured":"Evers S, Vollmer-Haase J, Schwaag S, et al.: Botulinum toxin A in the prophylactic treatment of migraine\u2014a randomized, double-blind, placebo-controlled study. Cephalalgia 2004, 24:838\u2013843.","journal-title":"Cephalalgia"},{"key":"3_CR46","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1111\/j.1468-2982.2007.01315.x","volume":"27","author":"M. Relja","year":"2007","unstructured":"Relja M, Poole AC, Schoenen J, et al.: A multicentre, double-blind, randomized, placebo-controlled, parallel group study of multiple treatments of botulinum toxin type A (BoNTA) for the prophylaxis of episodic migraine headaches. Cephalalgia 2007, 27:492\u2013503.","journal-title":"Cephalalgia"},{"key":"3_CR47","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1046\/j.1526-4610.2000.00066.x","volume":"40","author":"S. Silberstein","year":"2000","unstructured":"Silberstein S, Mathew N, Saper J, Jenkins S: Botulinum toxin type A as a migraine preventive treatment. For the BOTOX Migraine Clinical Research Group. Headache 2000, 40:445\u2013450.","journal-title":"Headache"},{"key":"3_CR48","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/S1474-4422(06)70382-9","volume":"5","author":"H.C. Diener","year":"2006","unstructured":"Diener HC, Kronfeld K, Boewing G, et al.: Efficacy of acupuncture for the prophylaxis of migraine: a multicentre randomised controlled clinical trial. Lancet Neurol 2006, 5:310\u2013316.","journal-title":"Lancet Neurol"},{"key":"3_CR49","doi-asserted-by":"crossref","first-page":"2118","DOI":"10.1001\/jama.293.17.2118","volume":"293","author":"K. Linde","year":"2005","unstructured":"Linde K, Streng A, Jurgens S, et al.: Acupuncture for patients with migraine: a randomized controlled trial. JAMA 2005, 293:2118\u20132125.","journal-title":"JAMA"},{"key":"3_CR50","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1111\/j.1468-2982.2006.01062.x","volume":"26","author":"J. Alecrim-Andrade","year":"2006","unstructured":"Alecrim-Andrade J, Maciel-Junior JA, Cladellas XC, et al.: Acupuncture in migraine prophylaxis: a randomized shamcontrolled trial. Cephalalgia 2006, 26:520\u2013529.","journal-title":"Cephalalgia"},{"key":"3_CR51","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/S0885-3924(99)00095-0","volume":"18","author":"E. Ernst","year":"1999","unstructured":"Ernst E: Homeopathic prophylaxis of headaches and migraine? A systematic review. J Pain Symptom Manage 1999, 18:353\u2013357.","journal-title":"J Pain Symptom Manage"},{"key":"3_CR52","unstructured":"Campbell J, Penzien DB, Wall EM: Evidence-based guidelines for migraine headache: behavioral and physical therapy. Available at http:\/\/www.aan.com\/professionals\/practice\/pdfs\/gl0089.pdf . Accessed July 2007."},{"key":"3_CR53","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1046\/j.1468-2982.2003.00624.x","volume":"23","author":"E. K\u00f6seoglu","year":"2003","unstructured":"K\u00f6seoglu E, Akboyraz A, Soyuer A, Ersoy AO: Aerobic exercise and plasma beta endorphin levels in patients with migrainous headache without aura. Cephalalgia 2003, 23:972\u2013976.","journal-title":"Cephalalgia"}],"container-title":["Current Treatment Options in Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11940-008-0003-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11940-008-0003-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11940-008-0003-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T20:56:52Z","timestamp":1559422612000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11940-008-0003-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,1]]},"references-count":53,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2008,1]]}},"alternative-id":["3"],"URL":"https:\/\/doi.org\/10.1007\/s11940-008-0003-3","relation":{},"ISSN":["1092-8480","1534-3138"],"issn-type":[{"value":"1092-8480","type":"print"},{"value":"1534-3138","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,1]]}}}